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difficult to quantify. The number of ECs potentially found in groundwater presents challenges for 21 
regulators and water managers regarding selection for monitoring. This study is the first systematic 22 
review of prioritisation approaches for selecting ECs that may pose a risk in groundwater. Online 23 
databases were searched for prioritisation approaches relating to ECs in the aquatic environment using 24 
standardised key word search combinations. From a total of 672, studies 33 met the eligibility criteria, 25 
based primarily on the relevance to prioritising ECs in groundwater. The review revealed the lack of a 26 
groundwater specific contaminant prioritisation methodology in spite of widely recognised differences 27 
between groundwater and surface water environments in regards to pathways to receptors. The findings 28 
highlight a lack of adequate evaluation of methodologies for predicting the likelihood of an EC entering 29 
groundwater and highlights knowledge gaps regarding the occurrence and fate of ECs in this 30 
environment. The review concludes with a proposal for a prioritisation framework for ECs in 31 
groundwater monitoring which enables priority lists to be updated as new information becomes 32 
available for substances regarding usage, physico-chemical properties and hazards.   33 
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1  Introduction  41 
Research on substances of emerging concern in the aquatic environment has expanded in recent years.  42 
They are often referred to as ‘emerging contaminants’ (ECs) and as substances “that are currently not 43 
included in routine monitoring programmes” and “may be candidates for future regulation, depending 44 
on research on their ecotoxicity” and “monitoring data regarding their occurrence” in the 45 
environment.1 In some cases they are also substances which still require the development of conceptual 46 
models to describe their behaviour and occurrence in the environment.2 ECs include pharmaceuticals 47 
and personal care products (PPCP), illicit drugs, hormones and steroids, industrial substances, 48 
disinfection by-products and pesticide degradation products.2-4 Approximately 860 ECs in the 49 
environment that are currently being researched or discussed.1 There has been an increase in the 50 
monitoring of ECs in the environment, largely due to advances in analytical chemistry techniques. 51 
Contaminants can be detected in concentration ranges below 1 ng/l that were previously below the Limit 52 
of Detection (LOD).3,5 New techniques include multi-residue gas and liquid chromatography techniques 53 
coupled with mass spectrometry.3,5   54 
The potential risks from ECs to human health and aquatic ecology in the environment have been 55 
recognised,6-8 and new standards and regulations may be required.2,9-11 ECs are now understood to be 56 
“ubiquitous contaminants in the environment” and there is evidence that these contaminants can have 57 
disruptive effects to organisms at different trophic levels, including humans.12 There is also growing 58 
concerns regarding the occurrence of pharmaceuticals in the environment and the build-up of antifungal 59 
and antibiotic resistance.13   60 
There remain many challenges for regulators and water managers regarding the monitoring of ECs in 61 
the aquatic environment.14 These challenges specifically relate to the lack of knowledge on their 62 
occurrence and fate, the number of ECs potentially present in the environment and the fact that many of 63 
them are unregulated.14,15  This is a particular concern for groundwater because the environmental fate 64 
of ECs is still not well understood.16,17 Groundwater is a valuable resource and amounts to 98% of the 65 
Earths’ freshwater18 and supplies approximately 50% of all drinking water globally.19 Drinking water 66 
treatment might only involve disinfection, meaning there is a risk of ECs contaminating supplies from 67 
groundwater.20 ECs have been detected in treated drinking water.16,20 Groundwater is also vital to the 68 
health of groundwater-dependent ecosystems such as rivers, lakes and wetlands.21   69 
1.1  Regulatory background  70 
In Europe, the Water Framework Directive (WFD) (2000/60/EC)22 requires Member States (MS) to 71 
manage water in an integrated ecosystem-based approach, and considers that all waters and their 72 
dependent ecosystems are inter-linked and inter-dependent. The key objective of the WFD is to establish 73 
good ecological status in all surface waters and good chemical and quantitative status in all groundwaters 74 
through a formal process until 2027. The WFD does not allow for deterioration in water body status.  75 
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The Groundwater Daughter Directive (GWDD) (2006/118/EC)21 further describes how the chemical 76 
status of groundwater bodies is defined using Threshold Values (TVs). They indicate environmental risk 77 
and trigger the requirement for further investigation.23 Many of the TVs relate to the protection of 78 
groundwater receptors such as rivers, groundwater-dependent terrestrial ecosystems or drinking water 79 
supplies.16,17 For many ‘classical’ contaminants there is sufficient information about the pathways and 80 
toxicity to receptors; however, not enough is known about ECs to define TVs.16   81 
A ‘chicken or egg dilemma’ prevails, as the gaps in knowledge relating to the occurrence and risk of 82 
ECs delay regulation and the lack of regulation delays the generation of monitoring data.24 The number 83 
of ECs makes it difficult to identify which ones should be monitored.25 In Europe, this has been 84 
addressed by developing a watch list for pollutants which aims “to increase the availability of 85 
monitoring data on substances posing a risk or potential risk to bodies of groundwater, and thereby 86 
facilitate the identification of substances, including emerging pollutants, for which groundwater quality 87 
standards or TVs should be set” (2014/80/EU).26 The first watch list under the Priority Substances 88 
Directive (2008/105/EC27 as amended by 2013/39/EU), has already been adopted for surface water in 89 
2015. Ten new substances including 17α-ethinylestradiol,17β-estradiol and diclofenac are listed.28   90 
A similar situation occurs elsewhere in the world for the regulation of ECs. The US Environment 91 
Protection Agency (USEPA) published a Contaminant Candidate List (CCL) for drinking water.29 This 92 
is required under the Safe Drinking Water Act (SDWA) for contaminants known or anticipated to occur 93 
in drinking waters and may require regulation in the future.29 The latest CCL (no. 4) from 2016 includes 94 
97 chemicals from industrial use, pesticides, disinfection by-products and pharmaceuticals.  95 
1.2  Emerging contaminants in groundwater  96 
Most research on ECs in the environment focuses on wastewater and surface water, while there has been 97 
less emphasis on groundwater.30 ECs have the potential to leach through subsoils to groundwater and 98 
have been detected in aquifers since the 1990s.31 ECs may get into groundwater from numerous origins 99 
as shown in Figure 1, but wastewater has been identified as the primary source.16 Point sources include 100 
private wastewater treatment systems, animal waste lagoons and landfill leachate.16 Managed artificial 101 
recharge of partially treated wastewater or surface water (i.e. bank infiltration) can also be important 102 
sources of ECs in groundwater.17 Diffuse sources include application of manure, pesticides, biosolids 103 
from sewage sludge, and atmospheric deposition.16,17,32,33   104 
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 105 
Figure 1 Sources of emerging contaminants and pathways towards receptors17  106 
  107 
Numerous studies in the USA34,35 and Europe17,30,36 provide an overview of the occurrence of ECs in 108 
groundwater. A global review of studies16 published since 1993 documented significant concentrations 109 
(102 to 104 ng/l) of ECs, which included a range of PPCPs (e.g. carbamazepine and ibuprofen), industrial 110 
compounds, and caffeine. Transformation products can be found more frequently, and in higher 111 
concentrations, than their parent compounds.4,16   112 
Previous studies have demonstrated that concentrations of ECs in surface waters are higher than those 113 
in groundwaters.7,34,35,37 In addition, the lists of ECs most frequently detected in groundwater differ from 114 
those in surface waters.7,34,35,37 For example, a comparative survey37 of 70 groundwater and 71 surface 115 
water samples in France, found that several pharmaceuticals detected in surface water were not present 116 
in groundwater. This is because the main source of ECs in the aquatic environment is wastewater 117 
effluent, which discharges directly into surface waters, while groundwater is generally less vulnerable 118 
to contaminants due to the protective properties of soils and the unsaturated zone. However, groundwater 119 
bodies in areas with an absence or only a thin layer of subsoils have increased vulnerability to 120 
contamination, including by ECs.38,39 The occurrence of ECs in United Kingdom, French and Italian 121 
groundwater, also showed higher concentrations in karstic aquifers relating to high transmissivity, and 122 
conduits.39,40 In addition to infiltration through the subsurface environment, another pathway of ECs to 123 
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groundwater is via surface water-groundwater exchange.16 There remain gaps in the understanding of 124 
EC sources, the pathways to receptors and toxicity mechanisms and levels.2   125 
1.3  Prioritisation approaches for monitoring contaminants in groundwater  126 
Given the lack of knowledge about the behaviour and impacts of ECs on groundwater receptors, many 127 
ECs are not routinely monitored in groundwater.2 Both the number of ECs, and the fact that not all of 128 
them will be harmful to human health or the aquatic environment, means that prioritisation is required 129 
to develop cost effective monitoring programmes that target the highest risk ECs, which may warrant 130 
regulation in the future.2,11,14 As demonstrated by previous studies35,37, EC occurrence in groundwater 131 
can differ from surface water; in regard to the types of contaminants, detection frequencies, and 132 
concentrations. Consequently, it appears inappropriate to use priority lists developed for surface waters.   133 
Existing techniques for prioritising chemicals are generally based on the principles of risk assessment.25  134 
The risk is the probability of the occurrence of exposure of a chemical to a biological receptor multiplied 135 
by the associated effect, known as the hazard.25 The way exposure and hazard are combined to calculate 136 
the risk, varies between prioritisation approaches and this can affect the results.41 There is no standard 137 
approach for prioritising ECs in groundwater. The Common Implementation Strategy Working Group 138 
for Groundwater (CIS WGGW, 2018) has outlined a process for developing a voluntary groundwater 139 
watch list (GWWL) at an EU level.42,43 The NORMAN Network1, a group of stakeholders interested in 140 
emerging contaminants (which includes academia, industry and regulators), are also developing a 141 
prioritisation methodology for groundwater (currently unavailable).  142 
Exposure relates to the environmental occurrence of a substance, which can be estimated using simple 143 
equations or environmental fate models.40,44,45 Occurrence in groundwater is not solely dependent on 144 
source factors and the characteristics of the pathway also warrant consideration.11,16 Migration through 145 
the subsurface is determined by several factors,4,46-49 such as physico-chemical properties of the 146 
compounds as well as those of soils and subsoils. Indices have been developed for estimating the 147 
leaching potential of contaminants (mainly for pesticides).50 Existing prioritisation approaches for 148 
groundwater have used these for characterising environmental exposure. For example: the Groundwater 149 
Ubiquity Score (GUS index)51  based on the physico-chemical properties of the compounds was used to 150 
prioritise pesticides in South African groundwater52; and the Attenuation Factor (AF) also based on the 151 
physico-chemical properties, as well as soil properties, the subsurface depth and recharge53 was used for 152 
estimating the leaching quantity of sixteen ECs in Ireland54.   153 
While there are numerous studies on the prioritisation of chemicals in the aquatic environment, there is 154 
a lack of consensus on critical components, such as determining exposure in groundwater and 155 
quantifying the hazard.10,55 Only one published study2 so far had specifically set out to review 156 
prioritisation for groundwater monitoring, but neither analysed approaches in detail nor proposed any 157 
groundwater specific techniques. Consequently, there is a need to review prioritisation techniques to 158 
Page 5  
determine the best approach for prioritising ECs in groundwater. This will help to focus groundwater 159 
monitoring efforts on those ECs that present the highest risk to human health or ecological receptors.  160 
To the authors knowledge this paper provides the first critical review of prioritisation approaches for 161 
selecting ECs for monitoring that may pose a risk in groundwater. It reviews existing approaches to 162 
provide a synthesis of their elements which may be appropriate for groundwater and to identify 163 
knowledge gaps. The specific objectives of the review are to: 1) review existing prioritisation approaches 164 
for ECs with an emphasis on methodologies that can be used for groundwater; 2) evaluate the 165 
methodologies within these prioritisation approaches for predicting EC occurrence in groundwater; 3) 166 
analyse the prioritisation results from a subset of studies to examine similarities and differences, and the 167 
impact of an approach on the result; and 4) describe a framework for a prioritisation approach for ECs 168 
in groundwater and make recommendations for further research.  169 
2  Systematic review criteria  170 
The systematic review was conducted following the general principles published in “The Production of 171 
Quick Scoping Reviews and Rapid Evidence Assessments”.56 A predefined protocol was developed by 172 
the authors and extracts are available in Supplementary Information A. The keywords searched are 173 
outlined Supplementary Information A, the record of results returned is in Supplementary Information 174 
B. The search source of published literature was the online database Scopus. Some of the recent work 175 
in this field has not been published within peer-reviewed journals, therefore, websites of relevant 176 
specialist organisations such as USEPA and EU Joint Research Council (JRC) were also searched.   177 
Following the screening of titles and abstracts, the remaining articles were examined in full to determine 178 
their eligibility for inclusion in further assessment. This selection generated a more focused group of 179 
studies to improve quality and the confidence of the analysis relating to the research question. A 180 
predefined scoring system for relevance and quality was developed as part of the protocol 181 
(Supplementary Information A). Studies were included if they had a relevant outcome (i.e. a prioritised 182 
list of chemicals for water quality monitoring purposes) and were of sufficient quality. The quality was 183 
determined through a process of critical appraisal to ensure only reliable studies were included. For 184 
example, criteria included: the study having a clear aim and transparent methodology. For the eligible 185 
studies, key information on the prioritisation approaches was extracted (see Supplementary Information 186 
A).  187 
3  Prioritisation approaches for monitoring ECs in groundwater   188 
3.1  Study characteristics from systematic review  189 
A total of 672 studies were identified and following the screening and eligibility assessment 33 studies 190 
were deemed eligible for inclusion in the review. The primary reason for exclusion was the lack of a 191 
relevant outcome, that is, the study did not include a prioritised list of chemicals for water quality 192 
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monitoring purposes. Summary results from this systematic review of published prioritisation studies 193 
are shown in Figure 2 (see Supplementary Information C (Table D) for details of the study 194 
characteristics). All studies were available in the English language and dated from 2003 to 2016. Many 195 
were published since 2014, accounting for 50 % of the studies included.  196 
  197 
Figure 2. Summary results from review of studies of prioritisation approaches for ECs, a) key 198 
contaminant groups included in published prioritisation approaches, b) range of environmental 199 
media, c) geographical coverage of studies, d) types of approaches for prioritisation. SW=surface 200 
water, GW=groundwater, DW=drinking water. Ph=human pharmaceuticals, Pv=veterinary 201 
pharmaceuticals, Legacy=regulated legacy contaminants, Pest=pesticides, OM=organic 202 
micropollutants,  PCP=personal  care  products,  EDC=endocrine  disrupting 203 
 compounds, DBP=disinfection by-products.  204 
Eight of the studies focused on ECs as a general category, with a further three examining legacy 205 
contaminants and ECs together (Figure 2a). Two studies were aimed specifically at organic 206 
micropollutants, three related to pesticides and one to disinfection by-products. Half of the studies (n = 207 
17) focused on pharmaceuticals in the environment. Ten of these studies were for human 208 
pharmaceuticals, five for veterinary and two for both. Two of the studies focusing on pharmaceuticals 209 
also included personal care products.   210 
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Only a very small proportion of published prioritisation studies were found to have a groundwater focus 211 
(Figure 2b). The majority of the studies were aimed at surface water (n = 21). A total of nine studies 212 
related to groundwater, with only two focused on groundwater (see Supplementary Information C (Table 213 
E) for full table of results). Five studies were aimed at both surface water and groundwater, and a further 214 
two for surface water, groundwater and drinking water.  215 
The selected studies were conducted in 13 different countries or regions (Figure 2c). Most of the studies 216 
were undertaken in European countries (n = 21), six at a European scale and four based in the United 217 
Kingdom. The USA also accounted for a significant number of the studies (n = 7).  Five studies were 218 
from other countries (Korea, China, South Africa, Iraq and Lebanon).   219 
The examined studies represent several different approaches of combining exposure and hazard 220 
assessments to determine risk, including the risk ratio approach, and scoring systems or matrices (Figure 221 
2d). Seventeen studies followed the risk ratio approach which was used slightly more frequently than 222 
the scoring system approach. The risk ratio approach relies on having the dose-response toxicological 223 
data for the relevant trophic levels and receptors but is considered a simple to use method and it is easy 224 
to communicate the results.57 A value above one indicates risk and may activate the substance's inclusion 225 
in monitoring programmes.10,44,58 The scoring approaches involved categorising and combining scores 226 
for exposure and hazard. For example, for exposure leaching indicators can be used and for hazards, 227 
classification data can be used instead of dose-response data. There were 15 scoring system approaches, 228 
three of which also used a matrix approach for combining the scores. Six of the studies used a 229 
combination of the risk ratio and scoring system approach. Examples were the EU WFD prioritisation 230 
studies58-60, where their first stage screening involved scoring chemicals based on the persistence, 231 
bioaccumulation and toxicity (PBT) approach and then the second stage prioritisation was based on the 232 
risk ratio approach.   233 
Only a very small proportion of published studies were found to have a groundwater focus and of those 234 
only one covered ECs specifically (Figure 2). This highlights the limited attention that has been paid to 235 
groundwater and groundwater receptors to date. The number of substances and groups of substances 236 
covered so far for both surface water and groundwater is also very limited, and the geographical coverage 237 
biased to Europe and USA. This emphasises the need for prioritisation approaches to now look beyond 238 
traditional hotspots of surface water and wastewater systems and consider approaches that are 239 
appropriate for the protection of groundwater bodies. A wider geographical scope is needed, and risk to 240 
groundwater from ECs may be region or country specific in terms of substances used, quantities used, 241 
as well as pathways for potential groundwater contamination. The tendency for prioritisation of 242 
pharmaceuticals, could lead to some other ECs escaping scrutiny.54 This may be referred to the “Matthew 243 
effect” whereby “the prominence of a few contaminants targeted for investigation is dictated largely by 244 
the attention devoted to them in the past”. 54 Some of the prioritisation studies10,57,61 which examined ECs 245 
and some classical contaminants had only included few pharmaceuticals in their priority lists.  246 
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3.2  Limitations of the study  247 
This review has several limitations including a risk of bias in the results because there were repetitions 248 
in the prioritisation approaches included. About half of the studies only updated existing approaches or 249 
applied them, and sometimes the same authors were involved in more than one study. This can result in 250 
showing trends in the approaches used, just because they have been used previously. The same is also 251 
true for the types of ECs studied due to the focus on pharmaceuticals. It was beyond the scope of this 252 
review to consider unpublished prioritisation approaches and therefore other approaches for 253 
prioritisation of ECs in groundwater may be applied in some countries that were not included. As 254 
discussed in Section 6 there were limitations with comparing the results of different prioritisation 255 
approaches and these should be addressed in future to help verify the results.  256 
4  Approaches for assessment of environmental exposure of ECs in groundwater   257 
This section describes the trends in the methods for exposure assessment, their applicability to the 258 
groundwater environment and highlights the strengths and weaknesses. Table 1 provides an overview 259 
of the characteristics of the exposure (and hazard) assessment in each of the studies.  260 
 261 Table 1 Summary approach to exposure and hazard assessment  
 
  Exposure     Hazard      
 
 Generic   Surface water  Groundwater  Receptors   Dose response     Classification    
Reference  
 
  
 
 
 
 
 
 
  
 
 
 
  
 
  
 
 
 
 
Boxall et al. 62      ●  ●            ●    ●  ●  ●                    
Capleton et al. 63    ●    ●              ●          ●    ●  ●  ●  ●  ●  ●  
Besse and Garric64     ●    ●  ●          ●    ●  ●  ●    ●    ●            
Kim et al.65    ●    ●            ●  ●          ●                
Kools et al.66  ●        ●          ●            ●                
USEPA29,67    ●  ●      ●    ●      ●          ●      ●  ●  ●      
Götz et al.25  ●  ●        ●                                    
Hebert et al. 68            ●    ●      ●                ●  ●        
Kumar and Xagoraraki69    
  
      
●  
      
●  ●  ●  ●  ●        ●  ●  ●  ●  ●  ●  
Murray et al.70            ●    ●      ●          ●                
Daginnus et al.59  
(WFD)  
●  ●  
    
●    
      
●  ●  ●  ●  ●      ●  ●  ●  ●  ●      
Diamond et al.57             ●        ●    ●  ●  ●      ●  ●        ●    
von der Ohe et al.10            ●        ●    ●  ●  ●                    
Coutu et al.71                    ●  ●          ●    ●  ●  ●        
Sui et al.11    ●      ●          ●    ●  ●  ●        ●            
Ortiz de García et al.72            ●        ●    ●  ●  ●      ●  ●            
Bouissou- Schurtz et al.73  
●    
    
●  ●  
      
●    ●  ●  ●                    
Dabrowski et al.52  ●  ●  ●            ●    ●                ●  ●  ●  ●  ●  
LaLone et al.74                    ●        ●                    
Maruya et al.75          ●  ●        ●        ●                    
Carvalho et al.(JRC)58  ●  ●      ●          ●  ●  ●  ●  ●    ●                
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Exposure  Hazard  
 
Generic  Surface water  Groundwater  Receptors  Dose response  Classification  
Reference  
 
  
 
 
 
 
 
 
  
 
 
 
  
 
  
 
 
 
 
(WFD)                         
Chirico et al.(JRC)60  
(WFD)  
●  ●  
    
●    
      
●  ●  ●  ●  ●      ●  ●  ●  ●  ●  ●    
Di Nica et al.76  ●    ●    ●          ●    ●  ●  ●                    
Ki et al.50  ●    ●            ●                              
Kuzmanović et al.77            ●        ●    ●  ●  ●                    
Al-Khazrajy and  
Boxall78  
  
  ●  
  
●    
      
●  ●  ●  ●  ●    ●                
Busch et al.79            ●        ●    ●  ●  ●                    
CIS WGGW43  ●              ●  ●  ●  ●  ●  ●  ●      ●  ●  ●  ●  ●  ●    
Clarke et al.54  ●        ●    ●        ●      ●                    
Donnachie et al.61            ●        ●    ●  ●  ●                    
Guo et al.80    ●      ●          ●  ●  ●  ●  ●  ●  ●                
Mansour et al.81    ●      ●          ●  ●  ●  ●  ●  ●    ●  ●            
Sangion and 
Gramatica82  
  
  
      
  
      
●    ●  ●  ●                    
262 Notes: a. Exposure assessment not included as part of this study. b. Hazard assessment not included as part of this study. Conc = concentration; SW = surface 
263   water; GW = groundwater.   
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The application of Measured Environmental Concentration (MECs) as a measure of environmental 263 
exposure was found to be a common approach (n = 17). MEC values from surface water were utilised 264 
in 13 of the included studies and four studies applied MEC values from groundwater. The use of MECs 265 
for groundwater are discussed further in Section 4.1.  266 
Calculating Predicted Environmental Concentrations (PEC) was also a common approach with a total 267 
14 studies using this approach to characterise exposure. Only one study calculated PECs specifically 268 
for groundwater. Sales or usage data was frequently used to estimate PECs (11 studies). It can be 269 
difficult to obtain the data required on sales, usage and environmental releases of ECs relevant to 270 
groundwater exposure. For example, it would be an enormous task to obtain usage data for all 271 
pharmaceutical compounds in the United Kingdom, and this type of information is not currently 272 
systematically reported or acessable.80 Two studies did not use sales or usage data to calculate the PEC: 273 
one study75 used wastewater effluent data to calculate PECs in surface water and the other study66 on 274 
veterinary pharmaceuticals used estimates of the number of animals.   275 
Five of the studies that calculated the PEC in surface water were for human pharmaceuticals using the 276 
European Medical Agency (EMA) guidelines83. Two of the studies calculated the PEC in surface water 277 
for veterinary pharmaceuticals using another EMA guideline84. The PEC in surface water was calculated 278 
using a European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Targeted Risk 279 
Assessment (TRA) Tool by the three WFD studies58-60, the first in 201159 and then in 201558,60. The 280 
latter also applied the FOCUS model in addition to the PEC calculation of pharmaceuticals in 281 
wastewater.58,60 PECs were therefore calculated mostly for surface waters using established methods for 282 
specific contaminant groups such as human or veterinary pharmaceuticals, or pesticides. In addition, 283 
none of these studies used MECs to validate the PECs. Only one study73 compared PEC and MECs and 284 
found a poor relationship that was not not scrutinised as part of the study.  285 
Five studies used neither MEC or PEC for characterisation of exposure in the water environment. Three 286 
of the studies62-64, used sales or usage data as an indicator of exposure in surface water. Each of the 287 
studies were for veterinary pharmaceuticals and all involved the same author which may bias the results.  288 
Overall only four studies43,50,52,54 predicted concentrations in groundwater or the likelihood of a 289 
contaminant entering groundwater (see Supplementary Information C). Two studies used neither the 290 
MEC or PEC approach and instead used leaching indicators: one study used the extended Attenuation 291 
Factor (AF)50 and another used the Groundwater Ubiquity Score (GUS index)52. The Groundwater 292 
Watch List (GWWL) study41 proposed a leaching indicator scoring system based on chemical properties 293 
and also incorporated MECs of ECs where they are available. The fourth study54 used a model which 294 
incorporated the AF and an application rate for biosolids to calculate PEC. Two of the studies focused 295 
on pesticides50,52 and two studies43,54 covered ECs; one of which considered only one source (spreading 296 
of biosolids)54 and the second4342 considered all ECs but this methodology has yet to be implemented at 297 
the EU level and will be done on a voluntary basis.  298 
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The review highlighted that there is no trend in the methodologies for predicting concentrations of ECs 299 
in groundwater or the likelihood of a contaminant entering groundwater. Therefore, rationales and the 300 
limitations of these methodologies have been examined in further detail in Sections 4.1 and 4.2.  301 
4.1  Measured Environmental Concentrations (MEC)  302 
The application of MECs as a measure of environmental exposure has been demonstrated as a common 303 
approach. It is a reliable representation of environmental exposure because the results represent actual 304 
occurrence rather than estimates. However, there is a dependency on availability of monitoring data 305 
which there may be a lack of for ECs. The EU WFD surface water prioritisation studies58-60 used 306 
monitoring data where possible and modelling was undertaken for substances where an insufficient 307 
quantity of monitoring data was available.58 The USEPA29,67 similarly used environmental release data 308 
and production data in the absence of MECs.  309 
There are further considerations when the MEC approach is used, which include how to summarise the 310 
data to be representative of the risk, and dealing with results below the LOD. Studies that used MECs 311 
commonly incorporated both the frequency of detection of a compound, as well as the magnitude of its 312 
concentration. Frequency addresses regularity of occurrence and the magnitude addresses intensity. 313 
Concentrations could change over time which is difficult to capture57 with the paucity of monitoring 314 
data of ECs in groundwater in particular. The magnitude can be represented by the mean concentration, 315 
the maximum or both.29,43,67 Most studies opted for the conservative approach of using the maximum 316 
concentration (e.g. 10,70,73,77). One study10 calculated the 95-percentile concentration of the sites to help 317 
account for spatial variations. Only a few studies reported whether the MECs were influenced by point 318 
sources such as wastewater treatment plants.    319 
The studies differed in their approaches to dealing with values below the LOD. Several studies10,29,67 320 
truncated the dataset by excluding data below the LOD. Alternatively, one study71 left censored data by 321 
replacement with the highest LOD value to take a more conservative approach. Caution should be taken 322 
when dealing with MEC datasets with a high proportion of censored results, (i.e. < LOD) and 323 
substitution methods, such as replacing non-detects with half the detection limit or zero, are not 324 
recommended for calculation summary statistics (mean, median, quartiles). Statistical approaches such 325 
as Maximum Likelihood Estimation (MLE) and Regression on Order Statistics (ROS) should be used 326 
for estimating summary statistics.84  327 
It can be argued that excluding less than values is appropriate in the context of prioritisation, because 328 
highly toxic chemicals that are frequently monitored but not often detected would result in a high risk, 329 
when in fact any risk is more likely to be low.10 Conversely, disregarding MECs below the LOD could 330 
possibly lead to an underestimation of the real risk if the ECs are hazardous but present at low levels 331 
that could still be harmful to human health or the environment.   332 
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4.2  Exposure assessments for the likelihood of a contaminant to enter groundwater  333 
4.2.1  Physico-chemical properties of ECs  334 
The likelihood of a contaminant entering groundwater is considered higher if the contaminants’ sorption 335 
coefficient is low (indicating higher mobility) and persistence is high,86 where persistence is defined as 336 
the long-term exposure to an organism and is based on the half-life data. 87 Two studies41,52 focussed on 337 
physico-chemical properties of ECs in their prioritisation.   338 
The GWWL methodology43 used a simple scoring system to indicate the likelihood of an EC reaching 339 
groundwater. The REACH guidelines87 provide indicators for persistent chemicals based on the halflife 340 
in water >40 days (P) and >120 days indicating very persistent (vP) chemicals. The GWWL scoring 341 
methodology for persistence was consistent with this and the Pesticide Properties Database (PPDB).86  342 
The GWWL methodology43 proposed two indicators for mobility: logKoc and logKow. Koc is the ratio of 343 
the concentration of the contaminant that is sorbed to the organic carbon in the soil versus that which is 344 
in solution.88 The Kow relates to the equilibrium partitioning of a contaminant between octanol and water 345 
phases and is a surrogate for Koc.88 The GWWL methodology43 gave higher risk scores for contaminants 346 
less likely to sorb to the soil and therefore more likely to reach groundwater. While this criterion is 347 
reasonable, the actual thresholds for the scoring in the methodology were neither explained nor justified.   348 
The second study52 to focus on physico-chemical properties of ECs utilised the GUS index as an 349 
indicator of environmental exposure to prioritise pesticides in South African groundwater. The GUS 350 
index applies the Koc and the half-life in soil52 and is widely used as an indicator of pesticide 351 
mobility52,89. They scored the pesticides with a GUS index of greater than 2.8 as highly mobile and 352 
those with a value of less than 1.8 as non-leachers. Again, this is consistent with the REACH 353 
guidelines87 and the PPDB86.  354 
Using EC physico-chemical properties has merits as a screening tool for determining the likelihood of 355 
an EC entering groundwater relative to other substances. However, there are also some obvious 356 
drawbacks and uncertainties. It is difficult to predict the half-life and mobility of chemicals in 357 
environmental field conditions, and they are dependent on variables including temperature, pH, 358 
moisture, microbial populations and the soil type.86,90,91 Many authors92,93  have illustrated that chemicals 359 
can be neutral or ionic depending on the soil pH and therefore their sorption capacity changes, and as a 360 
result logKow may not the be most universally appropriate indicator.94 Therefore, these methods are 361 
more appropriate for non-polar organic chemicals, such as pesticides, where they contribute to a better 362 
understanding of environmental fate and transport dynamics.95 However they may not be appropriate 363 
for non-polar ECs such as pharmaceuticals. Other studies have demonstrated a relationship between the 364 
frequency of detection of pesticides and the GUS index, but also revealed that some presumed “non-365 
leaching” pesticides were actually detected in groundwater.91  366 
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Neither study tested the sensitivity of their results for these leachability indicators. Also, the results were 367 
not verified by comparing the higher risk ECs with environmental data. These findings highlight that 368 
approaches that only use physico-chemical properties of ECs as leachability indicators can potentially 369 
mask or overestimate risks.   370 
4.2.2  Pathway to groundwater   371 
The vulnerability of groundwater to ECs is also dependent on many other factors including the 372 
physicochemical properties of the soil and subsoil, the depth to groundwater and the recharge rate. The 373 
AF (attenuation factor) is a simple index for ranking the leaching potential of pesticides and has been 374 
frequently used in the past (e.g. 95-97). It was proposed in 198553 and is based on the half-life of the 375 
pesticide, depth of the soil, bulk density, organic carbon, sorption coefficient and recharge rate.   376 
The extended AF was utilised in one study50 as part of a geospatial leaching tool for agrochemicals in 377 
the USA. It accounted for the properties of Volatile Organic Compounds (VOCs) as well as pesticides, 378 
by adding in the dimensionless Henry's constant (Kh) (air partition coefficient) and the diffusion 379 
coefficient in soil. They used digital mapping of annual pesticide usage, soil properties and recharge to 380 
examine the variation in potential leaching loads over a regional scale, and found it could distinguish 381 
between areas of high and low susceptibility.   382 
The second study54 to apply the AF adapted a model for estimating PECs of pesticides in groundwater 383 
for sixteen organic ECs detected in biosolids in Ireland. It calculated the leaching quantity as a function 384 
of the AF and the application rate, the fraction intercepted by the crop and the thickness of the 385 
unsaturated zone.   386 
Neither study attempted to verify their methods by comparing results with actual groundwater 387 
monitoring data. However, both studies50,54 did undertake a sensitivity analysis on the parameters and 388 
found that Koc and soil organic carbon were the most sensitive.  In research into uncertainty analysis on 389 
the AF method it was found that a small variation in the retardation factor (i.e. retention in the mobile 390 
phase) could lead to different prioritisation classifications98. The authors of the study using the 391 
geospatial leaching tool50 did acknowledge issues with the spatial and temporal map resolution. They 392 
emphasised the trade-off between the data availability and the accuracy of the predictions and concluded 393 
that their tool should only be used as a first step rapid and large-scale tool.50 Approaches that incorporate 394 
geographical information at a regional scale are now common practice (e.g. 99-103). Soil and groundwater 395 
models are considered to be less appropriate for generic risk assessments for determining monitoring 396 
programmes, as they can be too site specific.44  397 
A better understanding of the fate and transport of ECs in groundwater is required to inform risk 398 
assessments, particularly their sorption and degradation.16,104 In recent years, there have been several 399 
studies on the leaching potential of certain ECs, predominantly pharmaceuticals. For example, one 400 
research study104 examined the irrigation of soil columns and irrigated fields to assess the leaching 401 
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potential of acidic pharmaceuticals (ibuprofen, gemfibrozil, naproxen, ketoprofen, and diclofenac). At 402 
higher pH values (>8) these compounds tended to take their ionised more soluble state which increased 403 
their leaching abilities. However, no contamination of these pharmaceuticals in groundwater was 404 
observed.104 Another study105 found differing sorption of PPCPs with triclosan and octylphenol being 405 
moderately to strongly sorbed and negligible for carbamazepine. These authors demonstrated that 406 
microbial activity and soil organic carbon were important for the degradation. The relative persistence 407 
(28 to 39 days in unsterilized soils) and poor sorption of carbamazepine indicated that it is more likely 408 
to leach to groundwater.105 Other studies have also highlighted carbamazepine as being relatively 409 
persistent and being prone to accumulate in soil.104,106,107 Detections of carbamazepine have been 410 
observed in groundwater possibly as a result of the long-time available for downward migration due to 411 
its high persistence.104 Consequently there are many factors that may determine the presence of ECs in 412 
groundwater and research into their persistence and sorption capabilities in environmental conditions is 413 
still on-going. In addition, the lag time between environmental releases and the potential occurrence in 414 
groundwater needs to be considered when attempting to verify prioritisation approaches.    415 
4.3 Outlook for exposure assessments for the likelihood of an EC entering groundwater  The 416 
review found that the use of MECs is the preferred method for surface water and groundwater and more 417 
reliable more for representing environmental exposure especially for groundwaters where it is difficult 418 
to estimate the concentrations. Careful consideration is required when summarising data and dealing 419 
with results below the LOD so that the data is representative of the risk of exposure. Data should be 420 
summarised using statistically sound methods that are appropriate for the particular MEC dataset.  421 
However, there is still insufficient monitoring data for most ECs and therefore estimates will still be 422 
required.42 It is important therefore to generate a comprehensive list of ECs that have the potential to 423 
occur in groundwater that may not yet be measured. This initial list could be vast and therefore should 424 
be drawn up with the involvement of stakeholders.59 There is still a dependence on the availability of 425 
sales and usage data and data on the physico-chemical properties of ECs which is not as accessible as 426 
other contaminant groups that are regulated such as pesticides.42  427 
Unlike for surface water there are no standard methods for calculating PECs for ECs in groundwater. 428 
Only four studies were found to estimate the likelihood of an EC reaching groundwater or calculate 429 
PECs which all used slightly different approaches. Approaches that only use physico-chemical 430 
properties of ECs as leachability indicators can potentially mask or overestimate risks. Nevertheless, it 431 
should be acknowledged that these simple approaches can be useful as first steps in the development of 432 
monitoring programmes.52 However, from the studies reviewed it is not clear that they are treated as 433 
such, due to the lack of sensitivity testing of results, verification with monitoring data or other 434 
prioritisation studies and no mechanisms to update the methods with new data and understanding as 435 
they become available.   436 
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Depending on physico-chemical properties of the EC does not reflect real environmental 437 
conditions.84,90,91 In theory the two studies which incorporate the vulnerability of groundwater to 438 
contamination from ECs should provide a more accurate representation of the risk of exposure. 439 
However, similar to the approaches that use only physico-chemical properties of ECs, these methods 440 
that incorporate the pathway still do not verify the prioritised results with monitoring data. There is an 441 
inherent difficulty in doing this because the fate and transport of ECs may vary in different 442 
environmental conditions and there is also a lag time to consider for groundwater due to varying 443 
contaminant velocities through in the unsaturated zone. Also, care needs to be taken in the application 444 
of tools developed for certain organic contaminants to other ECs, such as acidic pharmaceuticals which 445 
may have very different mobility. Therefore, it is not possible to determine a completely unified 446 
approach for determining exposure of ECs in groundwater but it is clear that there is a requirement to 447 
incorporate new data and research on the sorption and degradation of ECs into any prioritisation 448 
approach to improve predictions of exposure.   449 
5  Approaches for hazard assessment of ECs in groundwater  450 
This section provides a review of the methods used to characterise the hazard in each of the studies 451 
included (Table 1). Twenty-five of the studies dealt with aquatic ecology as the receptor and sixteen for 452 
human health. The approaches for assessing the hazard were grouped into two different types: firstly 453 
those that used dose-response data and secondly that used classification data in the scoring system 454 
approach.   455 
5.1  Dose-response data hazard assessments  456 
Of the studies that used dose-response data (n = 29), 20 used ecotoxicological data for three trophic 457 
levels. Only two studies used mammalian toxicology data. Most of the studies reported using 458 
experimental data from existing databases and literature and eight studies reported using 459 
QuantitativeStructure-Activity-Relationship (QSAR) data, which estimate the effects based on 460 
structural properties of chemical compounds.108   461 
Ten studies used human dosage information as indicators of toxicity in humans, applying either the 462 
Acceptable Daily Dose (ADI) (n = 6) as “a measure of the amount of a specific substance in drinking 463 
water that can be ingested daily over a lifetime without an appreciable health risk”109 or Therapeutic 464 
Dose TD (n = 4) as the amount required to have the desired therapeutic effect. Only one study66, applied 465 
the therapeutic dose as a surrogate for toxicity data for aquatic ecology.   466 
For the nine studies that incorporated groundwater, six used dose-response data. Human health was the 467 
main receptor considered in these studies (n = 7) and only two considered aquatic ecology. The 468 
bioavailability of an EC was generally not accounted for in these approaches, with the exception of one 469 
study10 in this review which corrected the MEC for bioavailability. The lack of experimental 470 
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ecotoxicological data is considered the norm rather than the exception for many compounds.10,59 Recent 471 
studies have highlighted that ECs require further toxicological data to be developed.10,55   472 
Several authors10,64,72 emphasised that chronic toxicology data sets are the most appropriate to use for 473 
hazard assessments of ECs because the main concern relates to long-term exposure at relatively low 474 
concentrations. Availability of data for chronic exposure remains low and therefore a reliance on acute 475 
data was also highlighted by the same authors.10,64,61 A conservative approach proposed was to use the 476 
lowest available PNEC, even if it is an acute endpoint.10 Certain health effects cannot be predicted using 477 
acute or chronic dose-response tests.10 In one study57, different toxicological endpoints for ECs known 478 
to have estrogenic activity were used instead. This was the only study where this approach was 479 
undertaken, but few details were provided.   480 
5.2  Classification data hazard assessments  481 
Eleven studies used classification data to characterise the hazard. Only two of these studies did not use 482 
any dose-repose toxicity data in addition to the classification data. A number of studies incorporated 483 
specific long-term health effects data for carcinogenicity (n = 9), mutagenicity (n = 9), teratogenicity (n 484 
= 7), endocrine disruption (n = 6) and neurotoxicity (n = 3). Several studies also used persistence (n = 485 
6) and bioaccumulation (n = 11) properties of the EC for prioritising the hazard.   486 
Due the focus on human health in groundwater studies (7 of the 9 studies), the long-term health effects 487 
classification approach was used in five of the studies. Only two studies that incorporated groundwater 488 
used persistence or bioaccumulation as part of the hazard assessment. The advantages and 489 
disadvantages of these approaches for hazard assessment in groundwater are discussed in the following 490 
sections.   491 
5.2.1 Classification based on the persistence, bioaccumulation, and toxicity (PBT) assessment   492 
It has been suggested that the reason persistence has often been disregarded in prioritisation approaches 493 
is that it is less relevant when there is a continuous discharge into rivers. 57,77 However, for groundwaters 494 
persistence is an important factor because more persistent ECs are likely to leach and accumulate in 495 
groundwaters. The widespread detection of atrazine in groundwater today, several decades after it 496 
ceased being used, is an example of the importance of chemical persistence in groundwater.28  The PBT 497 
assessment is considered useful for circumstances where the risks are difficult to quantify44, which 498 
makes it relevant to the groundwater context. The PBT approach is also used in the United Kingdom to 499 
determine if substances are defined as hazardous in groundwater under the WFD and GWDD.110  500 
For the assessment of persistence, REACH guidelines87 definitions of the vP and P was used in the EU 501 
WFD prioritisation studies58-60. The USA study57 used a higher threshold of >180 to indicate persistent 502 
chemicals. The BIOWIN programme for organic substances can be used to estimate the 503 
biodegradability in environmental conditions.59,72 This was used in the EU WFD prioritisation 504 
studies5860  and a Spanish study72. For the assessment of toxicity in the PBT approach the studies 505 
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generally used the classification under the REACH guidelines87 or dose-response data, sometimes 506 
alongside the risk ratio approach.  507 
For the assessment of bioaccumulation, European guidance recommends that the bioconcentration 508 
factor (BCF) for aquatic species is used, mostly from fish.59,87 The BCF is the ratio of a substance’s 509 
concentration in an organism and its quantity freely dissolved in ambient water.59 This approach was 510 
used in only three of the studies in this review, with differing thresholds for risk. The logKow is also 511 
used to estimate a contaminants potential to bioaccumulate within an organism.64 Two studies59,64 used 512 
a threshold of a logKow > 4.5 to indicate a risk of bioaccumulation. This threshold originates from EMA 513 
guidelines66,87 which required pharmaceuticals to be screened for further assessment. The USA study57 514 
used a similar threshold of logKow >5, and another study69 used a threshold of 3, to indicate 515 
bioaccumulation potential. One of the studies64 did highlight the weaknesses of using logKow as an 516 
indicator of bioaccumulation for pharmaceuticals as they are mostly polar and ionisable. For ECs such 517 
as pharmaceuticals there has been little research on their bioaccumulation potential in biota.111  518 
5.2.2  Classification based on long-term health effects  519 
Studies that used long-term health effects data for hazard assessment did so to assess the risk to human 520 
health. One study52 scored ECs based on their potential to cause carcinogenic, teratogenic, mutagenic, 521 
endocrine disruption and neurotoxic effects. Its authors suggested that this method is more appropriate 522 
due to chronic exposure and endpoints such as carcinogenicity and endocrine disruption being realistic 523 
hazards. Another advantage of this method is that MECs or PECs are not necessarily required. Another 524 
study69 prioritised the hazard using seven categories for human health effects, which incorporated 525 
doseresponse ecotoxicology data for PPCPs and endocrine disrupting compounds for human health.   526 
Both of these studies52,69 used intermediate scores when there was no data to ensure that they were 527 
deemed higher risk than an EC classified as having no effect. It was emphasised by one of the studies69, 528 
that an important issue with these prioritisation approaches was lack of data for many of the health 529 
effects categories. The study found that 62% of data in the carcinogenicity category and 82% in the 530 
fertility impairment were missing, which resulted in a high uncertainty of results. The lack of an official 531 
definition of endocrine disrupting compounds also makes scoring ECs based on this criterion inherently 532 
difficult.60   533 
Weightings used to assign importance to different criteria are subjective.71 It therefore is a complex task 534 
and the easiest option can be to assign equal weightings to all different categories.69,72 For example, a 535 
study69 gave equal weight to health effects categories, whereas others such as, 52,63, weighted the scores 536 
to give more importance to carcinogenicity and mutagenicity. Expert judgement is used to assign 537 
weightings and can allow decision makers to set priorities; even the importance of different receptors, 538 
i.e. human health or aquatic ecology.69,71   539 
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5.3  Outlook for approaches for hazard assessment of ECs in groundwater  540 
The review highlighted that the use of dose-response toxicity data to characterise the hazard of ECs was 541 
the most common approach and only two studies did not use it. However, there is a paucity of toxicity 542 
data for many ECs and data is often not accessible due to protection from ‘commercial-in-confidence’.42   543 
The main concern of ECs in groundwater relates to long-term exposure at relatively low concentrations.  544 
In this context there are some issues with the prioritisation approaches reviewed. In particular the 545 
reliance on acute toxicological data rather than chronic toxicological data could misrepresent the risk. 546 
Only few studies considered chronic exposure endpoints such as carcinogenicity and endocrine 547 
disruption (approximately 28%) but there was a higher portion of the groundwater studies (55%) that 548 
did. There are also significant gaps in this type of toxicological classification data which can create high 549 
uncertainty in the hazard assessment results.  550 
Unlike surface waters the main source of ECs is not through rapid continuous discharges and therefore 551 
the accumulation of ECs is an important consideration. Only two groundwater studies used persistence 552 
or bioaccumulation as part of the hazard assessment. There is no standard approach for the assessment 553 
of bioaccumulation, and for ECs such as pharmaceuticals the evidence in the literature on their 554 
bioaccumulation potential in biota is still limited but is a growing research area.112-114  555 
When using the classification approach based on long-term health effects, weightings are generally used 556 
to assign importance to a criterion. These weightings are subjective and therefore sensitivity testing 557 
should be built into any prioritisation approach to understand the uncertainties and the robustness of the 558 
results.   559 
It is clear that greater accessibility and generation of toxicity data for ECs is required and that there are 560 
many uncertainties in the hazard assessment approaches. Future approaches for assessment of the 561 
hazard of ECs in groundwater should incorporate flexibility to update prioritisation results as new data 562 
becomes available, and research on the most appropriated approaches for groundwater are determined 563 
and refined.   564 
6  Comparison of prioritisation approaches  565 
Two subsets of prioritisation studies (ECs and pharmaceuticals) were analysed, to compare the 566 
chemicals on the prioritised lists to provide an indication of the impact of using different approaches on 567 
the results. Only substances that were classified as ECs by the NORMAN network (and not ‘classical’ 568 
contaminants) were included in the analysis. The selection process for studies and substances included 569 
are described in Supplementary Information A.   570 
The first subset of studies included five studies that prioritised ECs (see Supplementary Information D). 571 
There were 37 ECs included in this analysis. Only three ECs were prioritised in more than one of the 572 
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studies: diazinon, triclosan and estrone. Diazinon is a pesticide and is regulated in some countries so is 573 
not typically considered an emerging contaminant.   574 
The second subset of studies included six studies that prioritised human pharmaceuticals (see 575 
Supplementary Information D). There were 64 pharmaceuticals included in this analysis. The studies 576 
had been carried out in several different countries: United Kingdom80, two from France73,64, Iraq78, 577 
Lebanon81 and China11. Three pharmaceuticals were prioritised in five of the six studies: carbamazepine, 578 
diclofenac and ibuprofen. Three others were prioritised in four studies: amoxicillin, ciprofloxacin and 579 
clarithromycin. Overall a total of 20 of the 64 pharmaceuticals were prioritised in more than one study 580 
(31%).  581 
The comparison of prioritisation results for the two subsets of studies, has shown that there were more 582 
similarities between the prioritisation studies for pharmaceuticals. This can be attributed to the 583 
similarities between the initial lists of chemicals. The initial lists of pharmaceutical studies were 584 
generated from similar sources such as prescription and usage data but in several different countries. 585 
All the studies used the PEC and dose-response data. One study73 was an exception, its authors used the 586 
MECs and it did have fewer pharmaceuticals in common with the other studies.   587 
Three of the pharmaceutical studies also compared their ranking outcomes to results from other 588 
publications. In the first it was found that carbamazepine and ibuprofen were the most prioritised 589 
pharmaceuticals among the eight studies they examined.81 They also highlighted that six (out of 26) of 590 
their prioritised pharmaceuticals were not prioritised elsewhere.81 The second78 found that amoxicillin, 591 
which they ranked highest, also ranked highly in earlier studies in the United Kingdom and Korea (58,64). 592 
The third study11 compared its priority list to a previous review of prioritisation results for 593 
pharmaceuticals.114 Nine of the high priority pharmaceuticals had been identified in the previous 594 
review.11 The study’s authors also examined previous prioritisation research in France64 and 595 
Switzerland116 and found that there were similarities to their own list, despite the use of different 596 
methodologies.11   597 
The two EC studies that had more than one prioritised EC (triclosan and estrone) in common employed 598 
quite different methodologies. The initial lists of ECs were generated by different means and from 599 
different sources. The studies also had significantly different numbers of substances on their initial lists 600 
ranging from 34 to 2024 ECs (including classical chemicals prior to filtering), and were carried out in 601 
Europe and the USA. It is not surprising that the prioritisation results from EC studies reviewed here 602 
are variable. These studies can include a complex mixture of types of contaminants with different 603 
sources and pathways to the aqueous environment. The substances (Table F of the Supplementary 604 
Information) included pesticides applied to agricultural land that reaches water via runoff or infiltration 605 
through the soil (such as cyanazine or diazinon), pharmaceuticals and industrial fragrances (such as 606 
galoxalide) which probably enter the environment via wastewater, as well as plasticisers (bisphenol A) 607 
and flame-retardants (perfluorooctanoic acid).  608 
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One of the other studies57 in this review applied two hazard assessment approaches for ECs in surface 609 
water: a scoring system that incorporated persistence and bioaccumulation scores (PBT approach); and 610 
the risk ratio. The ECs identified by each approach were markedly different. The risk ratio approach 611 
yielded the lowest number (n = 41) compared with the PBT approach which used the risk ratio for 612 
toxicity (n = 60). Nearly half of the ECs identified by the first approach had relatively low half-lives 613 
(<60 days).   614 
It is apparent that comparing the prioritisation results to determine any commonalities is unsatisfactory 615 
without first analysing the initial lists (which unfortunately have rarely been provided) and assessing 616 
the substance type. Although most studies are therefore not directly comparable, it has been helpful to 617 
provide an indication of the parallels between the priority lists for pharmaceuticals.81 Given the 618 
uncertainties with developing any prioritisation approach,61 it is useful to make an attempt to evaluate 619 
the results through comparison with other similar prioritisation approaches. This has been undertaken 620 
in some studies (e.g. 11,78,81), but there was still a lack of analysis of the initial lists and differences 621 
between prioritisation methodologies. There is also merit in carrying out more than one prioritisation 622 
using different methods, or sensitivity testing results to understand the uncertainty surrounding the 623 
prioritised lists. This would minimise the risk of prioritising ECs that are lower risk or missing ones that 624 
could be higher risk in the groundwater environment e.g. persistent chemicals.   625 
7  Framework for prioritisation approaches and future outlook  626 
This review has demonstrated that a common approach for prioritising ECs in groundwater has not been 627 
developed and verified. Two main issues were revealed by the review.  Firstly, the groundwater 628 
exposure tools and models examined in this study all had merit, however they need to be confirmed 629 
using actual groundwater quality data50, whilst still considering the lag times. The level of detail 630 
required to provide realistic estimates of loading or concentrations in groundwater therefore remains 631 
unknown. For example, soil organic carbon was found to be important for sorption of ECs (e.g. 50,54) 632 
but some of the simpler approaches depend on the physico-chemical properties of the EC which often 633 
do not reflect real environmental conditions.84,90,91 There will always be trade-offs between complexity, 634 
accuracy and data requirements.117 The use of MECs is the preferred method for surface water and 635 
groundwater when adequate data is available. It is a more reliable method for representing 636 
environmental exposure especially for groundwaters where it is difficult to predict concentrations. 637 
Careful consideration is required when summarising MEC data and dealing with results below the LOD 638 
so that the data is representative of the risk of exposure.   639 
Secondly, the review has highlighted the paucity of toxicity data and physico-chemical data for ECs 640 
and issues with access to available data. Due to the risk of ECs accumulating and the potential chronic 641 
effects, the long-term health effects classification data will be important to incorporate.52,81 However, 642 
Page 22  
there are still significant gaps in chronic dose-response toxicological data and long-term health effects 643 
classification data for ECs.   644 
Lastly this review has indicated that no prioritisation approach is perfect, and it has not demonstrated 645 
that one approach is superior to any other, but has highlighted some important advantages and 646 
disadvantages. There is an indication that the most comprehensive prioritisation approaches are ones 647 
that use a combination of approaches, for example, the risk ratio and scoring methods for hazard 648 
assessment (e.g. 57,81). It has also been shown that the persistence of the EC is important in the 649 
groundwater context with the example of carbamazepine accumulation in soil and leaching to 650 
groundwater.104 The dose-response hazard classification can omit highly persistent ECs57 and the 651 
possibility of bioaccumulation of ECs.   652 
The uncertainties with the results of any prioritisation approach require greater effort in scrutinising the 653 
results, sensitivity test them and comparing them with other similar studies. Further research is required 654 
to analyse the advantages of different prioritisation approaches to optimise the best one for ECs in 655 
groundwater. Prioritisation of ECs should not be a static process and improvements in the approaches 656 
should be sought and incorporated. Future prioritisation approaches should incorporate flexibility to 657 
update prioritisation results as new data becomes available.   658 
Therefore, a broad framework is proposed, that facilitates the incorporation of research on the 659 
occurrence, hazards and prioritisation of ECs and an evaluation process. A phased approach adapted for 660 
groundwater from Maruya et al.75 is proposed as outlined in Figure 3. The figure also highlights the key 661 
priority research areas of: 1) sorption and degradation of ECs in the environment; 2) evaluation of 662 
different exposure characterisation approaches to confirm the level of detail required to provide 663 
estimates of loading or concentrations in groundwater; 3) the chronic toxicity of ECs and health 664 
classification data; 4) comparison of prioritisations approaches for groundwater. For example, the effect 665 
of combining prioritisation approaches such as the risk ratio and scoring approaches could be 666 
researched, as well as the influence of including persistence and bioaccumulation as factors.  667 
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669 Figure 3 A phased framework for prioritisation of ECs in groundwater 
incorporating key  
670 research requirements     
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This framework and future research will hopefully enable the prioritisation methodologies to be 671 
improved by feeding back results from the evaluations of the prioritisation approach and allowing the 672 
incorporation of new data. This phased approach could also be verified with existing monitoring data 673 
for ECs in groundwater.  674 
The first phase involves developing the conceptual understanding and approach. The first step is to 675 
define the objectives of the prioritisation approach. This ought to be done by both scientists and policy 676 
makers or decision makers,2 determining the priorities (human health, aquatic ecology or both). In 677 
addition, it would be important to consider the scale of occurrence to be considered. The WFD, for 678 
example, would require that both human health and ecology are considered and the occurrence to be 679 
examined at a groundwater body scale.42,43   680 
The next step would be to develop the initial conceptual model for the source, pathway and receptors 681 
of ECs in groundwater. Given the wide variety of ECs and difference in source types, it is considered 682 
that a pragmatic approach would be to develop scenarios that focus on certain sources and groups of 683 
substances that can then be tested.42,75 Such scenarios for groundwater could be designed around the 684 
current understanding of the sources of ECs (see Figure 117). One exemplary scenario could relate to 685 
the ECs found in wastewater discharges from septic tanks and other private treatments works which 686 
discharge to groundwater. It would also be important to monitor in areas with high and low groundwater 687 
vulnerability to be representative of the risk spectrum43 and allow different groundwater vulnerability 688 
settings to be tested.  689 
The second phase involves the actual prioritisation process. A prioritisation approach that is appropriate 690 
for groundwater and the identified receptors needs to be selected. An initial priority list of ECs to be 691 
monitored can be developed based on the characterisation of environmental exposure and hazard. The 692 
results of the prioritisation of ECs should be sensitivity tested to understand the level of uncertainly 693 
around the data used and any scores or weightings. Carrying out more than one prioritisation approach 694 
using the same initial list and a further analysis of the resulting priority lists would help to ensure that 695 
results are robust and that the decision makers are informed of the uncertainties that require 696 
consideration.  697 
The third phase involves monitoring the prioritised ECs in groundwater and verifying the conceptual 698 
models and exposure characterisation by relating the MECs to the exposure scenario.75 The monitoring 699 
can then be adapted as needed based on the monitoring results and evaluation studies (see Figure 3).75 700 
The lag times between environmental release and occurrence in groundwater needs to be reflected. This 701 
evaluation step can also be used to adapt the prioritisation approach if required and reassess 702 
prioritisation results. Additional feedback loops are proposed to incorporate new physico-chemical data 703 
and hazard classification and toxicity data.   704 
Page 25  
The framework addresses the problem of the lack of knowledge on occurrence and fate of ECs, and 705 
uncertainties surrounding prioritisation results. The prioritisation process needs to be dynamic and 706 
responsive as new information becomes available, for example, through the proposed voluntary 707 
European GWWL process, refinements can also be made to the conceptual models and subsequent 708 
priority lists. The framework will ultimately enable further groundwater monitoring data to be gathered 709 
for ECs that pose the highest risk to groundwater receptors, while paving the way for an optimised 710 
approach for prioritising ECs in groundwater.   711 
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